[go: up one dir, main page]

AU2994997A - Aptamers for complement protein c3b - Google Patents

Aptamers for complement protein c3b

Info

Publication number
AU2994997A
AU2994997A AU29949/97A AU2994997A AU2994997A AU 2994997 A AU2994997 A AU 2994997A AU 29949/97 A AU29949/97 A AU 29949/97A AU 2994997 A AU2994997 A AU 2994997A AU 2994997 A AU2994997 A AU 2994997A
Authority
AU
Australia
Prior art keywords
aptamers
complement protein
complement
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29949/97A
Inventor
Augustine Y.-T. Lin
Henry C. Marsh Jr.
Sue Ellen Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
T Cell Sciences Inc
Original Assignee
T Cell Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Cell Sciences Inc filed Critical T Cell Sciences Inc
Publication of AU2994997A publication Critical patent/AU2994997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3517Marker; Tag

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU29949/97A 1996-05-07 1997-05-01 Aptamers for complement protein c3b Abandoned AU2994997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64617496A 1996-05-07 1996-05-07
US08646174 1996-05-07
PCT/US1997/007354 WO1997042317A1 (en) 1996-05-07 1997-05-01 APTAMERS FOR COMPLEMENT PROTEIN C3b

Publications (1)

Publication Number Publication Date
AU2994997A true AU2994997A (en) 1997-11-26

Family

ID=24592066

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29949/97A Abandoned AU2994997A (en) 1996-05-07 1997-05-01 Aptamers for complement protein c3b

Country Status (2)

Country Link
AU (1) AU2994997A (en)
WO (1) WO1997042317A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395888B1 (en) * 1996-02-01 2002-05-28 Gilead Sciences, Inc. High affinity nucleic acid ligands of complement system proteins
US6140490A (en) * 1996-02-01 2000-10-31 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands of complement system proteins
DE69739880D1 (en) * 1996-02-01 2010-07-01 Gilead Sciences Inc HIGHLY AFFINITY NUCLEAR ACID SIGNS FOR THE C1q PROTEIN OF THE COMPLEMENT SYSTEM
AU2001296305B2 (en) 2000-09-26 2007-12-06 Duke University RNA aptamers and methods for identifying the same
PT1401853E (en) 2001-05-25 2010-12-07 Univ Duke Modulators of pharmacological agents
US7803931B2 (en) 2004-02-12 2010-09-28 Archemix Corp. Aptamer therapeutics useful in the treatment of complement-related disorders
CN103045601B (en) 2004-04-22 2015-04-01 雷加多生物科学公司 Improved modulators of coagulation factors
JP5101288B2 (en) 2004-10-05 2012-12-19 カリフォルニア インスティテュート オブ テクノロジー Aptamer-regulated nucleic acids and uses thereof
WO2009012263A2 (en) 2007-07-18 2009-01-22 The Trustees Of Columbia University In The City Of New York Tissue-specific micrornas and compositions and uses thereof
US20120165387A1 (en) 2007-08-28 2012-06-28 Smolke Christina D General composition framework for ligand-controlled RNA regulatory systems
US8865667B2 (en) 2007-09-12 2014-10-21 California Institute Of Technology Higher-order cellular information processing devices
US9029524B2 (en) 2007-12-10 2015-05-12 California Institute Of Technology Signal activated RNA interference
US8927509B2 (en) 2008-05-20 2015-01-06 The Research Foundation Of State University Of New York Aptamer modulators of complement protein C3 and biologically active proteolytic products thereof
US9599591B2 (en) 2009-03-06 2017-03-21 California Institute Of Technology Low cost, portable sensor for molecular assays
US9145555B2 (en) 2009-04-02 2015-09-29 California Institute Of Technology Integrated—ligand-responsive microRNAs
CN104220453B (en) 2012-04-03 2018-03-09 诺沃姆德治疗公司 Inosculating antibody factor C3 antibody of humanization and application thereof
ES2776029T3 (en) 2012-10-08 2020-07-28 St Jude Childrens Res Hospital Therapies based on the control of the stability and function of regulatory T cells by means of a neuropilin-1 axis: semaphorin
NO2718257T3 (en) 2014-05-30 2018-04-14
SG10202002486QA (en) 2014-06-16 2020-04-29 Univ Johns Hopkins Compositions and methods for the expression of crispr guide rnas using the h1 promoter
EP3289104B1 (en) 2015-04-29 2020-11-04 New York University Method for treating high-grade gliomas
KR20220139886A (en) 2020-01-08 2022-10-17 리제너론 파아마슈티컬스, 인크. Treatment of Progressive Osteogenic Fibrodysplasia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434257A (en) * 1992-06-01 1995-07-18 Gilead Sciences, Inc. Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages

Also Published As

Publication number Publication date
WO1997042317A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
AU2994997A (en) Aptamers for complement protein c3b
AU4922497A (en) Interleukin-18-receptor proteins
AU1847497A (en) Protein expression system
AU6721696A (en) Cd44-like protein
AU2850497A (en) Block former
ZA9710338B (en) Proteins
AU127863S (en) Sunglasses
AU8596498A (en) Annexin binding protein
AU3640397A (en) Ob protein binding protein
AU4586497A (en) Calcium-integrin binding protein
ZA968185B (en) Protein.
AU5137598A (en) Novel protein
ZA971900B (en) Modified proteins
AU7869798A (en) Antimicrobial proteins
ZA973709B (en) Proteins.
GB9707599D0 (en) Proteins
GB9607689D0 (en) Proteins
EP0960198A4 (en) Cd44-like protein
CA78739S (en) Sunglasses
CA78768S (en) Sunglasses
CA78868S (en) Sunglasses
CA78762S (en) Sunglasses
CA78761S (en) Sunglasses
CA78272S (en) Sunglasses
CA78871S (en) Sunglasses